Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Featured Stories


GC3 Announces Preservative Challenge Winners; Sponsors Exploring Partnership Possibilities

Avisco, a biotech startup focused on the antimicrobial properties of the Inula viscosa plant, and IMD Natural Solutions, whose INS Glycolipid mushroom extract purportedly is “up to 80 times more effective than traditional preservatives,” are among winners named Aug. 6 by GC3.

Cosmetic Ingredients Innovation Consumer

Stakeholders Converge On California For Animal-Testing Bill Showdown

California lawmakers returning Aug. 6 from summer recess will have cosmetics industry reps and animal welfare groups vying for their ears, with the legislative clock ticking on a highly contentious proposal, SB 1249, to prohibit the sale of cosmetics containing ingredients tested “for any purpose” on animals.
Legislation State News Animal Testing

Cruelty Free International Seeks ‘More Humane’ REACH With Phase-In Registrations Now Wrapped

The NGO unveiled a six-point plan in July to reduce animal suffering under the European chemical regulation. Needs include greater funding to advance alternative methods and less red tape to encumber their regulatory approval, according to the animal-welfare group.

Animal Testing Regulation Europe

Cyclamate Found In GU, Roctane Brand Energy Products On Recall

Recall of 35 products started July 18 by Advanced Food Concepts follows recalls started in June of four products by Prinova US and one by Sisel International also found to contain cyclamate.

International United States Consumer
Advertisement

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.
 

 

Pharma Report Store

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop Now

Regulation Explore this Topic

Set Alert for Regulation

Latest From Regulation

Failed NDIs, FDA's Opioid Concerns Don't Stop Kratom Supplement Sales

Proponents say the herbal ingredient extracted from a plant in the coffee family and available in powders, capsules or pills and beverages has been used in the US since long before the October 1994 grandfather date for ingredients to be eligible for use in supplements without being notified to FDA as new. But FDA wants NDI notifications, and the four submitted so far have been incomplete or did not show safety for intended use in a supplement.

United States Dietary Supplements

Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop

While FDA does not identify specific product types on the agenda for its public workshop on approaches in skin toxicity testing for topical drug products, advocacy and trade groups anticipate sunscreen ingredient testing could be among the discussion topics. Product expansions have been stifled by regulatory concerns, drawing particular attention from the public health community.

United States Advertising, Marketing & Sales

Kratom Group Contests FDA's Opioid Finding, Requests Joint Meeting With NIDA

American Kratom Association accuses FDA of using “inaccurate, extrapolated and distorted” information on adverse events and deaths allegedly associated with the use of kratom to justify scheduling it as a controlled substance. After FDA Commissioner Gottlieb says the criticism is unfounded and kratom has no future as a dietary ingredient in the US, the group asks for joint meeting with NIDA to discuss "public health policy that allows for consumers to safely use natural kratom."

United States Consumer

Nutrition Labeling, Food-Borne Illness Shape FDA’s ‘Healthy People 2030’ Goals

FDA combines two surveys from the Healthy People initiative that tackles a range of consumer health topics every 10 years into a single survey, “FDA Food Safety, Health and Diet Survey.” The separate surveys have been deployed since 1990, “Food Safety Survey” and “Health and Diet Survey.” 

United States Consumer

Oral B Pro Most-Recommended Claim Backed By P&G's Global Dentist Surveys

UK Advertising Standards Authority says it rejected a complaint challenging whether the claim “number one dentist recommended brand worldwide” that P&G made in a TV ad was misleading and could be substantiated. P&G Health & Beauty Care Ltd. business in England responds with explanation of surveys with dentists it commissions to determine the professionals' regards for Oral B manual and power brushes.

United Kingdom United States

Supplements Recalled With Artificial Sweetener Banned In US Since 1970

Prinova US recalls four products, two each marketed with its brand and the Amino Life brand, and Sisel International recalls one product under the SiselRipt brand. Although banned in US, cyclamate remains available in other countries, including in popular brand artificial sweeteners distributed in Canada.

United States Advertising, Marketing & Sales

Legislation Explore this Topic

Set Alert for Legislation

Latest From Legislation

Appropriators Agree On Boosting FDA's Supplement Sector Work, Not On Funding

House and Senate appropriation bills state markedly different funding levels for FDA's spending on research into supplement and food products by its Center for Food Safety and Applied Nutrition and on enforcement work in the field by the Office of Regulatory Affairs. Appropriators are more aligned, though, in requests to FDA about its oversight of dietary supplement manufacturing and marketing.

United States Advertising, Marketing & Sales

Exclusivity Period Allowed By OTC Monograph Reform Likely Up To Conference Committee

Next step for OTC monograph reform legislation is Senate consideration; market exclusivity periods are likely focus of House/Senate conference. Separate bill to allow consumers to use health savings accounts to buy OTC drugs without a doctor's prescription clears House Ways and Means panel.

Legislation Consumer

Adding Multivitamins To SNAP Sprouts Or Wilts In Congress' Decision On Farm Bill

House appoints its farm bill conference committee members primarily from Agriculture Committee but also with reps from committees with oversight for a variety of topics due to the breadth of the legislation and to contentious issues unrelated to including supplements as SNAP, or food stamp, benefits. Supplement industry also looks to fate of legislation that would allow using pre-tax health savings accounts to buy OTC drugs without having a doctor's prescription as a sign for whether VMS product purchases will be allowed with the accounts, as proposed in House and Senate bills.

Legislation Advertising, Marketing & Sales

Legal Explore this Topic

Set Alert for Legal

Latest From Legal Issues

L’Oreal/Matrix Hair Care May Be Weighing Settlement In Case Of Missing Keratin

Plaintiffs scored class certification Aug. 15 in their false advertising suit against L’Oreal USA and its Matrix Essentials professional hair-care subsidiary, alleging that despite labeling and advertising cues, Biolage Keratindose hair products contain no keratin. Defendants’ motion to dismiss was largely denied in late 2017.

Legal Issues Consumer

Target Cruises Past Hypoallergenic Cosmetic Suit, But Other Defendants On Rockier Road

The plaintiff in a proposed class action against Target Corporation for alleged “hypoallergenic” cosmetic fraud neglected to venture a definition for the term and focused to a distracting extent on claims ultimately found to be non-actionable puffery – e.g., “gentle.” Other hypoallergic suits pending around the US are built on sturdier ground and likely will be harder to dismiss.

Legal Issues Consumer

Plaintiff Digs Deep In Almay Archives For ‘Hypoallergic’ Fraud Evidence

In the absence of FDA regulations, federal courts generally are weighing hypoallergenic false-advertising arguments against the “reasonable consumer” standard, with varying results. However, Almay may have provided a more substantive basis for assessing the truthfulness of its hypoallergenic claims via a letter to FDA on the subject – albeit one from 1973.

Legal Issues Consumer

Commercial Explore this Topic

Set Alert for Commercial

Failed NDIs, FDA's Opioid Concerns Don't Stop Kratom Supplement Sales

Proponents say the herbal ingredient extracted from a plant in the coffee family and available in powders, capsules or pills and beverages has been used in the US since long before the October 1994 grandfather date for ingredients to be eligible for use in supplements without being notified to FDA as new. But FDA wants NDI notifications, and the four submitted so far have been incomplete or did not show safety for intended use in a supplement.

United States Dietary Supplements

E.l.f. Cut Down To Size As US Distribution Gaps Shrink, Fans’ Eyes Wander

After recording boast-worthy sales increases of 20% and 18% in fiscal 2016 and 2017, respectively, e.l.f.’s growth is tapering off faster than anticipated. The company will counter with brand investments, better storytelling and sharper product mix in retailer doors, among other initiatives.

Sales & Earnings Business Strategies

Toxicity Testing For Topical Drugs, Sunscreens Included, On Tap In US FDA Workshop

While FDA does not identify specific product types on the agenda for its public workshop on approaches in skin toxicity testing for topical drug products, advocacy and trade groups anticipate sunscreen ingredient testing could be among the discussion topics. Product expansions have been stifled by regulatory concerns, drawing particular attention from the public health community.

United States Advertising, Marketing & Sales

Ingredients Explore this Topic

Set Alert for Ingredients

Plaintiff Digs Deep In Almay Archives For ‘Hypoallergic’ Fraud Evidence

In the absence of FDA regulations, federal courts generally are weighing hypoallergenic false-advertising arguments against the “reasonable consumer” standard, with varying results. However, Almay may have provided a more substantive basis for assessing the truthfulness of its hypoallergenic claims via a letter to FDA on the subject – albeit one from 1973.

Legal Issues Consumer

NMI/J&J Study Probes Consumer Relationship With ‘Fragrance-Free’

Improved transparency is needed in fragrance labeling and ingredient disclosure, as well as greater “precision” in fragrance-free claims, but the demonization of all fragrance must stop, NMI researchers say, in partnership with J&J.

Cosmetic Ingredients Market Intelligence

FDA Analysis Of Non-Traditionally Preserved Cosmetics Indicates Likely Contamination Source

The agency’s survey of eye-area cosmetics marketed as free of traditional preservatives doesn’t raise any obvious red flags. However, it does point to a possible contamination source and suggests “the limits of preservative activity in cosmetics.”

FDA Cosmetic Ingredients

Dietary Supplements Explore this Topic

Set Alert for Dietary Supplements

Latest From Dietary Supplements

Failed NDIs, FDA's Opioid Concerns Don't Stop Kratom Supplement Sales

Proponents say the herbal ingredient extracted from a plant in the coffee family and available in powders, capsules or pills and beverages has been used in the US since long before the October 1994 grandfather date for ingredients to be eligible for use in supplements without being notified to FDA as new. But FDA wants NDI notifications, and the four submitted so far have been incomplete or did not show safety for intended use in a supplement.

United States Dietary Supplements

Kratom Group Contests FDA's Opioid Finding, Requests Joint Meeting With NIDA

American Kratom Association accuses FDA of using “inaccurate, extrapolated and distorted” information on adverse events and deaths allegedly associated with the use of kratom to justify scheduling it as a controlled substance. After FDA Commissioner Gottlieb says the criticism is unfounded and kratom has no future as a dietary ingredient in the US, the group asks for joint meeting with NIDA to discuss "public health policy that allows for consumers to safely use natural kratom."

United States Consumer

Health, Beauty And Wellness News: MusclePharm Results, F-Factor 'Bundle,' Fitamin CBD Brand

MusclePharm expands distribution, cuts loss; F-Factor package shakes with diet book; and Fitamin brand acquired for CBD supplements.

United States Advertising, Marketing & Sales
UsernamePublicRestriction

Register

Advertisement